Friday 6 November 2026 Export WGS’s income statement to Excel — free account

GeneDx Holdings Corp.

GeneDx Holdings Corp.’s revenue for fiscal 2025 (year ended December 2025) was $427.5 million, up 40.0% from fiscal 2024.

Revenue: +11.4%
EPS: −257.9%
Free cash flow: −585.6%
Total debt: +87.4%

Quarter to June 2026, against a year earlier

65.42 1.06 +1.65%

Follow WGS

Alert me

Market cap: $1.9B
P/E: 0.0×
Fwd P/E: −20.6×
Dividend yield: —
F-score: 6/9
Altman Z: 7.80
Beneish M: −2.36
Dividend safety: n/a

Overview

GeneDx Holdings Corp. (WGS) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, GeneDx Holdings Corp. (WGS) trades at a P/S ratio of 4.2×. Over the past ten years it has ranged from 0.0× (September 2021) to 12.0× (November 2025); the current reading is higher than 69% of that period. That is in line with the Diagnostics & Research industry median of 4.2× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/WGS/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="GeneDx Holdings Corp. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/WGS/metrics/ps-ratio">GeneDx Holdings Corp. (WGS) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	8.7×	28.77%
FY2024	6.8×	2,035.22%
FY2023	0.3×	2,497.54%
FY2022	0.0×	(82.27%)
FY2021	0.1×	—
FY2020	0.0×	—
FY2019	0.0×	—

Period	P/S ratio	Change
Jun 2026	4.5×	5.47%
Mar 2026	4.3×	(51.16%)
Dec 2025	8.7×	12.94%
Sep 2025	7.7×	5.95%
19 more quarters	Free account

Against its own ten years

Low 0.0× High 12.0×

Ten-year median 0.5×

Current reading's percentile 63

Company	P/S ratio
FRNM Freenome, Inc compare	n/m
OPK OPKO Health, Inc. compare	2.6×
NEO NeoGenomics, Inc. compare	2.7×
CSTL Castle Biosciences, Inc. compare	2.8×
VCYT Veracyte, Inc. compare	3.3×
WGS GeneDx Holdings Corp.	4.2×
CDNA CareDx, Inc. compare	8.1×
ADPT Adaptive Biotechnologies Corporation compare	14.5×
PSNL Personalis, Inc. compare	20.7×
Diagnostics & Research industry median	4.2×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

GeneDx Holdings Corp. (WGS) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on WGS

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on WGS

Stockrow Weekly